Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia
Closed
Phase 3
This trial is looking at using ofatumumab with bendamustine or chlorambucil chemotherapy for people with chronic lymphocytic leukaemia who cannot have intensive treatment. This trial is supported by Cancer Research UK.
Recruitment start: 14 December 2011
Recruitment end: 30 April 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Andrew Pettitt
Cancer Research UK
Chugai Pharma UK Ltd
Experimental Cancer Medicine Centre (ECMC)
Gilead
GlaxoSmithKline (GSK)
NIHR Clinical Research Network: Cancer
Napp Pharmaceuticals
This is Cancer Research UK trial number CRUKE/10/052.
Last reviewed: 9 March 2018
CRUK internal database number: 6958
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
